510(k) Report

FDA applicant

Htl-Strefa S.A

Ozorkow, PL7 decisions2015–20250 recalls

FDA records 7 decisions for Htl-Strefa S.A (Ozorkow, PL) from 2015 to 2025: 7 510(k) clearances. Most are in product codes FMI (Needle, Hypodermic, Single Lumen) and FMK (Single Use Only Blood Lancet With An Integral…). Since 2016 its 510(k)s took a median of 253 days from receipt to decision, against 253 for FDA’s reviews in the same codes and years. Its devices cite 8 predicates, 2 of them its own earlier devices. No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, general hospital panel, where it files most

How often FDA has decided Htl-Strefa S.A’s devices, and how often a recall has named them.

FDA decisions per year

1in 2025

2015: 12017: 12018: 12020: 22022: 12025: 1
2015high 2 (2020) · low 0 (2016)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2015.

FIG. 1 — Htl-Strefa S.A by year, 2015–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Htl-Strefa S.A’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report